SJMHE1 treatment did not alter IgE levels, suggesting that application of small peptide molecules from schistosomes and other helminths as potential drugs for allergic asthma or other allergic diseases may represent a safer therapy pipeline compared with utilizing a live worm infection or whole parasite proteins, which may elicit unwanted side effects in patients. The gene discussed is IGHE; the disease is allergic asthma.